Super-stable homogeneous iodinated formulation technology for improving the therapeutic effect of patients with advanced hepatocellular carcinoma.
作者信息
He Pan, Zhong Furui, Luo Bin, Luo Guosong, Wang Xuewen, Xia Xianming, Li Bo
机构信息
Department of General Surgery (Hepatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Academician (Expert) Workstation of Sichuan Province, Luzhou, China.
出版信息
Quant Imaging Med Surg. 2020 Nov;10(11):2223-2226. doi: 10.21037/qims-20-741.
Abstract
摘要
相似文献
1
Super-stable homogeneous iodinated formulation technology for improving the therapeutic effect of patients with advanced hepatocellular carcinoma.
Quant Imaging Med Surg. 2020 Nov;10(11):2223-2226. doi: 10.21037/qims-20-741.
2
Clinical characteristics and survival outcomes of super-elderly hepatocellular carcinoma patients not indicated for surgical resection.
Hepatol Res. 2016 Mar;46(3):E5-E14. doi: 10.1111/hepr.12514. Epub 2015 Apr 7.
3
Transarterial chemoembolization in a patient with severe reactions to iodinated contrast: Successful treatment using gadolinium contrast with C-arm computed tomography.
Radiol Case Rep. 2018 Dec 4;14(3):299-303. doi: 10.1016/j.radcr.2018.11.011. eCollection 2019 Mar.
4
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly].
Nihon Shokakibyo Gakkai Zasshi. 1999 Feb;96(2):142-6.
5
Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
Dig Liver Dis. 2005 Apr;37(4):254-9. doi: 10.1016/j.dld.2004.11.002. Epub 2005 Jan 8.
6
[Development of non-iodized oily agent in targeting chemoembolization for hepatocellular carcinoma].
Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Sep;58(11):581-3.
7
Effect of the herbal formulation Jianpijiedu on the TCRVβCDR3 repertoire in rats with hepatocellular carcinoma and subjected to food restriction combined with laxative.
Exp Ther Med. 2016 Mar;11(3):818-826. doi: 10.3892/etm.2015.2955. Epub 2015 Dec 23.
8
Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis.
ACS Appl Mater Interfaces. 2019 Apr 24;11(16):14526-14537. doi: 10.1021/acsami.8b20600. Epub 2019 Feb 27.
9
Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma.
Hepatol Res. 2012 May;42(5):454-8. doi: 10.1111/j.1872-034X.2011.00952.x. Epub 2012 Feb 1.
10
Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Jpn J Clin Oncol. 2011 Jan;41(1):69-75. doi: 10.1093/jjco/hyq145. Epub 2010 Aug 5.
引用本文的文献
1
Optical molecular imaging technology and its application in precise surgical navigation of liver cancer.
Theranostics. 2025 Jan 1;15(3):1017-1034. doi: 10.7150/thno.102671. eCollection 2025.
2
Superstable homogeneous lipiodol-ICG formulation: initial feasibility and first-in-human clinical application for ruptured hepatocellular carcinoma.
Regen Biomater. 2022 Dec 16;10:rbac106. doi: 10.1093/rb/rbac106. eCollection 2023.
本文引用的文献
1
A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatment.
J Control Release. 2020 Jul 10;323:635-643. doi: 10.1016/j.jconrel.2020.04.021. Epub 2020 Apr 14.
2
Indocyanine green-loaded injectable alginate hydrogel as a marker for precision cancer surgery.
Quant Imaging Med Surg. 2020 Mar;10(3):779-788. doi: 10.21037/qims.2020.02.24.
3
The effect of light sensitizer localization on the stability of indocyanine green liposomes.
J Control Release. 2018 Aug 28;284:213-223. doi: 10.1016/j.jconrel.2018.06.029. Epub 2018 Jun 28.
4
fluorescence imaging of hepatocellular carcinoma using a novel GPC3-specific aptamer probe.
Quant Imaging Med Surg. 2018 Mar;8(2):151-160. doi: 10.21037/qims.2018.01.09.
5
Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.
Surg Endosc. 2017 Dec;31(12):5111-5118. doi: 10.1007/s00464-017-5576-z. Epub 2017 Apr 28.
6
In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma.
Mol Pharm. 2017 Feb 6;14(2):448-458. doi: 10.1021/acs.molpharmaceut.6b00886. Epub 2017 Jan 5.
7
Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes.
Quant Imaging Med Surg. 2015 Oct;5(5):730-9. doi: 10.3978/j.issn.2223-4292.2015.10.04.
8
In vivo chemoembolization and magnetic resonance imaging of liver tumors by using iron oxide nanoshell/doxorubicin/poly(vinyl alcohol) hybrid composites.
Angew Chem Int Ed Engl. 2014 May 5;53(19):4812-5. doi: 10.1002/anie.201402144. Epub 2014 Mar 25.
9
Chemoembolization for intermediate HCC: is there proof of survival benefit?
J Hepatol. 2012 Apr;56(4):984-6. doi: 10.1016/j.jhep.2011.08.017. Epub 2011 Oct 17.
10
Epidemiology and management of hepatocellular carcinoma.
Infect Dis Clin North Am. 2010 Dec;24(4):899-919, viii. doi: 10.1016/j.idc.2010.07.004.
Zotero 插件